SEARCH RESULTS FOR: "Tag: IBB"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2018(3)
2017(11)
2016(10)
2015(8)
CATEGORIES
5-Minute Market Rundown(1)
Bernie's Content(2)
By the Numbers(4)
Expectational Analysis(5)
Indexes and ETFs(12)
Intraday Option Activity(10)
Midday Market Check(1)
Options Recommendations(1)
Quantitative Analysis(3)
Stock Market News(9)
Stocks On the Move(8)
Strategies and Concepts(1)
Technical Analysis(2)
Unusual Trading Activity(1)
VIX and Volatility(2)

5/11/2018 2:32 PM
Healthcare stocks are in focus this afternoon, after President Donald Trump unveiled a plan lower drug prices not long ago, entitled "American Patients First." The sector is trading higher following t...
4/11/2018 2:03 PM
Biotechs struggled in the latter half of March, with the iShares Nasdaq Biotechnology ETF (IBB) shedding more than 13% from its mid-March high of $115.60 to its early April lows just north of $100. Th...
3/13/2018 3:03 PM
Pharmaceutical stocks went on a tear recently, with the iShares Nasdaq Biotechnology ETF (IBB) fresh off a seven-day winning streak -- its longest series of consecutive gains since March 2015. While...
12/8/2017 2:38 PM
It's a big day for biotechs, with Denali Therapeutics (DNLI) debuting on the Nasdaq above its initial public offering price (IPO), and Sage Therapeutics (SAGE) continuing to hit record highs. Amid th...
9/18/2017 2:46 PM
The biotech sector has generated some keen interest lately, driven in no small part by the recent FDA approval of the first CAR T-cell therapy for cancer treatment. This development has been the focus...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center